MEI Pharma Inc (MEIP)
2.90
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
2.50
-0.40
(-13.79%)
After-Hours: 20:00
MEI Pharma SG&A Expense (TTM): 23.30M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 23.30M |
March 31, 2024 | 29.12M |
December 31, 2023 | 31.70M |
September 30, 2023 | 32.18M |
June 30, 2023 | 33.13M |
March 31, 2023 | 28.93M |
December 31, 2022 | 30.69M |
September 30, 2022 | 30.12M |
June 30, 2022 | 30.54M |
March 31, 2022 | 31.40M |
December 31, 2021 | 28.68M |
September 30, 2021 | 26.41M |
June 30, 2021 | 24.41M |
March 31, 2021 | 22.31M |
December 31, 2020 | 19.96M |
September 30, 2020 | 18.50M |
June 30, 2020 | 16.72M |
March 31, 2020 | 15.93M |
December 31, 2019 | 15.70M |
September 30, 2019 | 15.33M |
June 30, 2019 | 14.60M |
March 31, 2019 | 13.31M |
December 31, 2018 | 12.16M |
September 30, 2018 | 10.70M |
June 30, 2018 | 9.787M |
Date | Value |
---|---|
March 31, 2018 | 9.158M |
December 31, 2017 | 8.824M |
September 30, 2017 | 8.436M |
June 30, 2017 | 8.628M |
March 31, 2017 | 8.638M |
December 31, 2016 | 8.476M |
September 30, 2016 | 8.451M |
June 30, 2016 | 7.601M |
March 31, 2016 | 7.674M |
December 31, 2015 | 7.869M |
September 30, 2015 | 8.339M |
June 30, 2015 | 8.948M |
March 31, 2015 | 7.736M |
December 31, 2014 | 7.542M |
September 30, 2014 | 7.076M |
June 30, 2014 | 6.448M |
March 31, 2014 | 6.158M |
December 31, 2013 | 5.392M |
September 30, 2013 | 4.861M |
June 30, 2013 | 3.964M |
March 31, 2013 | 3.695M |
December 31, 2012 | 3.281M |
September 30, 2012 | 2.759M |
June 30, 2012 | 2.734M |
March 31, 2012 | 3.402M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
15.33M
Minimum
Sep 2019
33.13M
Maximum
Jun 2023
25.25M
Average
27.55M
Median
SG&A Expense (TTM) Benchmarks
Avid Bioservices Inc | 27.90M |
Ionis Pharmaceuticals Inc | 258.76M |
United Therapeutics Corp | 581.80M |
Hepion Pharmaceuticals Inc | 7.932M |
Mira Pharmaceuticals Inc | 6.936M |